Juvederm vs Restylane: Differences, Cost & Which Is Better (2026)

Juvederm and Restylane are the two most recognized names in hyaluronic acid dermal fillers in the United States, and the comparison confuses people for one simple reason: neither is a single product. Juvederm is a collection of gels made by Allergan Aesthetics, part of AbbVie. Restylane is a family of gels made by Galderma. Asking whether Juvederm is better than Restylane is a bit like asking whether one car brand is better than another without saying whether you need a pickup or a compact. The question that actually produces a good result is which specific gel, placed in which specific area, by which injector.

That said, the two families are not interchangeable, and the differences between them are real rather than marketing. They are built with different cross-linking technologies, which changes how each gel feels under the skin, how far it spreads, how much water it attracts and how much structural support it gives. They also hold different FDA approvals, so the very same treatment can be an on-label use for one brand and an off-label use for the other. This guide covers what the two share, where they genuinely differ, which products suit which areas, the risks of both, realistic cost ranges and how to choose.

FDA status, stated plainly. Juvederm and Restylane products are FDA approved class III medical devices, approved individually as products rather than as brands, each for named treatment areas in adults over the age of 21. Juvederm Volbella XC and Restylane Eyelight both hold FDA approval for undereye hollowing. Juvederm Volux XC is approved for jawline definition, while jawline treatment with Restylane products is off-label. Restylane Lyft is approved for the backs of the hands, while hand treatment with Juvederm is off-label. Nonsurgical nose reshaping, earlobe rejuvenation and several other popular requests are off-label for both brands. Off-label use is legal and common in aesthetics, but it should be named out loud. This is educational content, not medical advice.

Juvederm vs Restylane at a glance

The short version: both brands make cross-linked hyaluronic acid gels that add volume, soften folds, hydrate tissue and can be dissolved if you dislike the result. The broad tendency, and it is a tendency rather than a rule, is that Juvederm gels are smoother and more cohesive, so they spread and integrate evenly for a soft, blended look, while Restylane gels built on the original NASHA technology are firmer and more particulate, so they stay where they are placed and give projection and definition. Restylane's newer XpresHAn products soften that distinction considerably, which is why product level comparisons beat brand level ones. Duration is driven by the individual product and the treated area rather than by the brand, and both families contain options that hold from roughly six months to around two years. The table below sets out the head to head attributes this guide then explains in detail.

What the two filler families have in common

Start with the similarities, because they outweigh the differences. Both brands use hyaluronic acid produced by bacterial fermentation rather than harvested from animals, then chemically cross-linked so the gel resists breakdown for months instead of days. Hyaluronic acid is a sugar molecule your skin already makes, which is why allergy testing is not routinely required for either brand and why true hypersensitivity is uncommon. Both hold their volume partly through the material itself and partly by binding water in the surrounding tissue, and both are gradually broken down by your own enzymes until the result fades and the area returns to its starting point.

Both are regulated identically. In the United States, dermal fillers are class III medical devices, the highest risk category, and each product must clear premarket approval with its own clinical data before it can be marketed for a named area in adults over 21. That is why approvals are product specific rather than brand wide: Restylane as a brand is not approved for the jawline, and Juvederm as a brand is not approved for hands. Both families also offer versions premixed with lidocaine, which makes treatment noticeably more comfortable, and both are placed in a routine office visit with little or no downtime.

The most important shared trait is reversibility. Because both are hyaluronic acid, both can be dissolved with injected hyaluronidase, an enzyme that breaks the gel down within hours to days. This is the single biggest safety advantage hyaluronic acid holds over collagen biostimulators such as Sculptra and Radiesse, which have no reversal agent at all. It is also the reason hyaluronidase counts as emergency equipment rather than a convenience: if filler compromises a blood vessel, dissolving it quickly is the treatment. Any injector using either brand should stock it and be able to describe their protocol without hesitating.

How the gels are made, and why texture differs

The differences people notice in the chair trace back to manufacturing. Restylane's original technology is NASHA, short for non-animal stabilized hyaluronic acid. It uses relatively little chemical modification and leaves the gel in a particulate, granular form. The result resists deformation, so it holds a defined shape and lifts, which is why Restylane Lyft is a common choice when someone wants visible cheek projection. Galderma's second technology, marketed as XpresHAn or OBT, produces a smoother, more flexible gel designed to stretch and move with facial expression. Refyne, Defyne, Kysse and Contour sit in that group, and they behave much less like the stereotype of a firm Restylane gel.

Juvederm uses two technologies of its own. Hylacross, in the Ultra and Ultra Plus products, produces a smooth, malleable, homogeneous gel with a relatively high hyaluronic acid concentration. Vycross, in Voluma, Volbella, Vollure and Volux, blends high and low molecular weight hyaluronic acid, which allows efficient cross-linking at a lower total concentration. In practice that tends to mean a very cohesive gel, less water attraction and therefore less early swelling than older high concentration formulas, and longer duration in several of the products.

The technical shorthand clinicians use is elastic modulus, written G prime, which describes how much a gel resists deformation. Higher G prime products project and lift; lower G prime products spread and blend. A 2019 analysis in Plastic and Reconstructive Surgery measured rheologic and physicochemical properties across eighteen hyaluronic acid fillers and concluded that G prime is a useful and consistent way to tell products apart, with wide variation between individual gels. The honest reading of that work is that product level differences are meaningful while brand level generalizations are weak. Head to head randomized comparisons between a named Juvederm product and a named Restylane product remain limited, and where they exist the differences in patient satisfaction are usually small.

Product families and what each is FDA approved to treat

The Juvederm collection covers most of the face. Juvederm Ultra XC is approved for lip augmentation and for facial wrinkles and folds, and Ultra Plus XC targets deeper folds. Vollure XC is approved for nasolabial folds. Volbella XC is approved for lips, perioral lines and undereye hollowing, an indication granted in 2022 that came with a mandatory manufacturer training program for injectors. Voluma XC is approved for cheek augmentation, chin augmentation and, since March 2024, moderate to severe temple hollowing. Volux XC is approved for jawline definition. SKINVIVE by Juvederm is a different category altogether: a hyaluronic acid microdroplet injected intradermally to improve cheek skin smoothness rather than to add contour.

The Restylane family is at least as broad. Restylane and Restylane-L are approved for moderate to severe facial wrinkles and folds and for lip enhancement. Lyft with lidocaine is approved for cheek augmentation and midface contour deficiencies, chin augmentation, facial folds and volume loss in the backs of the hands. Silk is approved for lip augmentation and perioral wrinkles, and Kysse for lip augmentation and upper perioral lines. Refyne and Defyne are approved for nasolabial folds, with Defyne also approved for chin augmentation. Contour is approved for cheek augmentation, midface contour deficiencies and temple hollowing. Eyelight, approved in 2023, is a NASHA gel indicated for infraorbital hollowing.

Comparing the two labels side by side produces the clearest practical differences in the whole comparison. If you want the backs of the hands treated with an on-label product, Restylane Lyft is the option. If you want a jawline treated with an on-label product, Juvederm Volux XC is the option. Both brands now offer an FDA approved undereye product and an FDA approved temple product, which was not true a few years ago and which quietly outdates a lot of older comparison articles. Everything outside those labels, including nonsurgical nose reshaping, earlobes, buttocks and most neck work, is off-label for both brands.

Which filler suits which area and which goal

Lips are the most searched decision, and both brands are strong here. Juvederm Ultra XC gives softer, fuller, more diffuse volume and is often chosen when someone wants an obvious increase in size. Volbella XC is lighter, favored for subtle hydration, definition and vertical lip lines. Restylane Kysse is built on the flexible XpresHAn technology and is often described as preserving natural movement while defining the lip border, while Silk is the fine grained option for detail work and perioral lines. On the frequently asked question of which filler looks most natural, the evidence points at the injector rather than the label: naturalness is driven by how much product is used, where it is placed and how the lip is balanced against the rest of the face.

For cheeks and midface, Juvederm Voluma XC is highly cohesive and among the longest lasting hyaluronic acid options, while Restylane Lyft projects firmly and Restylane Contour is the softer, more expressive choice for people who dislike a rigid looking cheek. Under the eyes, both Volbella XC and Eyelight are approved, both are extremely technique sensitive, and neither is right for every candidate: prominent fat pads, significant fluid retention or festoons often make filler the wrong tool regardless of brand. For nasolabial folds, Vollure XC and Ultra Plus XC compete with Refyne and Defyne, and the choice usually turns on how much the fold moves when you smile.

Candidacy limits apply equally to both. Neither is appropriate with active skin infection or inflammation at the treatment site, known hypersensitivity to hyaluronic acid, or known allergy to lidocaine in the lidocaine containing versions. A history of severe allergic reactions or anaphylaxis is a contraindication for several products. Bleeding disorders and blood thinning medication raise bruising risk and need discussing in advance. Neither brand has been studied in pregnancy or breastfeeding, so injectors generally advise waiting, and neither is approved for anyone under 21.

Risks and safety of both fillers

The common side effects are the same for both brands and are usually mild and temporary: swelling, redness, bruising, tenderness, itching, firmness and small lumps at the injection site, typically settling within a few days to two weeks. A 2023 systematic review and meta analysis in Cureus found these events are not evenly distributed across the face. The midface, perioral area and lips showed more swelling, lumps and firmness than the nasolabial folds, while pain, bruising, redness and itching were broadly similar wherever the product went. That is a useful expectation setter, and it is a fact about anatomy rather than about brand.

Less common problems deserve naming. Hyaluronic acid placed too superficially under thin skin can scatter light and cast a bluish tint, called the Tyndall effect, seen most often under the eyes. Delayed onset nodules and late inflammatory reactions can appear weeks, months or occasionally years after treatment, sometimes triggered by illness, dental procedures or vaccination, and have been reported across hyaluronic acid fillers including products from both families. Infection and biofilm formation are rare but possible, and asymmetry or lumpiness from uneven placement is a technique problem rather than a product problem.

The serious risk, and the one the FDA highlights above all others, is unintentional injection into a blood vessel. Blocked blood flow can cause tissue death and skin ulceration, and when the arteries around the nose and eyes are involved it can cause vision loss or stroke. The chance is low, but the consequences can be permanent. This risk is managed by anatomical knowledge, injection technique, cannula choice and immediate access to hyaluronidase, not by picking one brand over the other. The FDA also warns against fillers used for large volume body contouring such as breasts and buttocks, and against needle free filler devices sold online. There is no brand level safety winner here: both families are well studied, and the injector is the dominant variable in whether treatment goes well.

Cost comparison and what actually drives the price

Both brands are sold per syringe, usually one millilitre, which at least makes them directly comparable, unlike biostimulators sold per vial. Across the United States a single syringe commonly runs somewhere in the region of $550 to $1,200, with premium long lasting formulas such as Voluma XC and Volux XC sitting toward the top of that band and entry level products lower. Treat those figures as broad ranges rather than quotes: real pricing swings with region, injector credentials, practice type and how much product your anatomy actually needs, and only a consultation produces a real number.

On the popular question of why Juvederm seems more expensive than Restylane, the answer is usually that there is no brand wide gap. The perception comes from a mix of things. Juvederm's Vycross products are premium priced and are often the first thing quoted. Cheeks, chins and jawlines simply need more product than lips, so a Juvederm heavy treatment plan for the midface will always look costlier than a single Restylane lip syringe. And the two brands run different loyalty programs, Alle for Juvederm and ASPIRE Galderma Rewards for Restylane, which shift the effective price in ways that never appear on a price list. Compare like for like, meaning the specific product, the syringe size and the number of syringes, before concluding that one brand costs more.

The fairer comparison is cost per year of result. A syringe that costs more but holds for eighteen to twenty four months can work out cheaper annually than a less expensive product repeated every nine months. Ask whether the quoted price includes a follow up visit and any touch up product, since a two week review is standard practice. And be cautious with deep discounts: the FDA warns against filler bought online or injected outside a clinical setting, and a syringe that arrives unlabeled or already unsealed is a reason to end the appointment.

How to choose, and why the injector outranks the brand

The honest verdict is the one the marketing avoids. For most people in most areas, Juvederm and Restylane deliver comparable results, and the available evidence does not establish either brand as superior overall. The differences that genuinely matter are product level. Choose Juvederm's Vycross gels when you want maximum longevity in the cheeks or a jawline product with an FDA approval behind it. Choose Restylane's NASHA gels when you want firm projection or an on-label option for hands, and its XpresHAn gels when you want a filler that moves naturally with expression. In lips, both families have excellent options and the look depends far more on volume and placement than on which box the syringe came out of.

Then apply the rule that outranks the product decision entirely. Ask your injector which specific product they are proposing and why that one, whether your intended use is on-label or off-label for that product, how many syringes they expect over how many visits, what the total cost is including follow up, and what happens if you dislike the result. Ask whether they keep hyaluronidase on site and what their protocol is for a suspected vascular occlusion. That last question tells you more about your safety than any brand comparison ever will.

Look for a licensed medical professional with specific experience in the area you want treated, ideally a board certified dermatologist or plastic surgeon, or an appropriately supervised nurse practitioner, physician assistant or registered nurse practising within your state's rules. Ask to see their own before and after photographs of your treatment area rather than manufacturer stock images, and look at faces built like yours. A good injector will tell you when the answer is a different product, a different area or no filler at all, and will name an off-label use as off-label without waiting to be asked.